Taysha Gene Therapies, Inc. (TSHA)
Biological Products, (No Diagnostic Substances)
Latest Price
$5.06
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.05
P/B Ratio
4.81
Institutional Ownership
91.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 23.89M | $162.0M | 7.34% | +2.19M | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 23.56M | $160.0M | 7.24% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 22.71M | $154.0M | 6.98% | +343.5K | 2026-06-30 |
| BlackRock, Inc. | 20.69M | $140.0M | 6.36% | +2.33M | 2026-06-30 |
| Vestal Point Capital, LP | 19.41M | $132.0M | 5.97% | +1.42M | 2026-06-30 |
| MORGAN STANLEY | 16.49M | $112.0M | 5.07% | -1.48M | 2026-06-30 |
| RTW INVESTMENTS, LP | 13.56M | $92.0M | 4.17% | -120.0K | 2026-06-30 |
| FMR LLC | 13.34M | $90.0M | 4.10% | -984.8K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.48M | $84.0M | 3.84% | +2.25M | 2026-06-30 |
| STATE STREET CORP | 11.42M | $77.0M | 3.51% | +212.8K | 2026-06-30 |